Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Biglycan anticorps (C-Term)

BGN Reactivité: Humain, Rat, Souris, Chien WB, EIA Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN375174
  • Antigène Voir toutes Biglycan (BGN) Anticorps
    Biglycan (BGN)
    Épitope
    • 16
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 50
    • 37
    • 32
    • 18
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain, Rat, Souris, Chien
    Hôte
    • 65
    • 5
    • 1
    Chèvre
    Clonalité
    • 58
    • 13
    Polyclonal
    Conjugué
    • 30
    • 14
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Biglycan est non-conjugé
    Application
    • 55
    • 20
    • 18
    • 16
    • 13
    • 13
    • 9
    • 7
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Séquence
    C-DRLAIQFGNY KK
    Specificité
    This antibody recognizes Biglycan Preproprotein.
    Réactivité croisée (Details)
    Species reactivity (expected):Mouse, Canine.
    Species reactivity (tested):Human, Rat.
    Purification
    Ammonium Sulphate Precipitation followed by Antigen Affinity Chromatography using the immunizing peptide
    Immunogène
    Synthetic peptide from the C-Terminus of Human Biglycan (NP_001702.1) Genename: BGN
    Top Product
    Discover our top product BGN Anticorps primaire
  • Indications d'application
    Peptide ELISA: 1/8000. Western Blot: 0.1 - 0.3 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Tris saline, pH ~7.3, 0.02 % Sodium Azide, 0.5 % BSA
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    Biglycan (BGN)
    Autre désignation
    Biglycan (BGN Produits)
    Synonymes
    anticorps DSPG1, anticorps PG-S1, anticorps PGI, anticorps SLRR1A, anticorps BG, anticorps BSPG1, anticorps bgn, anticorps zgc:91989, anticorps dspg1, anticorps pg-s1, anticorps slrr1a, anticorps xbgn, anticorps BGN, anticorps zgc:77123, anticorps DKFZp468I2427, anticorps biglycan, anticorps biglycan L homeolog, anticorps biglycan a, anticorps biglycan S homeolog, anticorps biglycan b, anticorps BGN, anticorps Bgn, anticorps bgn.L, anticorps bgna, anticorps bgn.S, anticorps bgn, anticorps bgnb
    Sujet
    Biglycan is an extracellular matrix proteoglycan that is closely related in structure to decorin and fibromodulin. Biglycan and decorin are thought to be the result of a gene duplication. Biglycan is expressed in secondary myotubes during fetal muscle formation. In adult muscle it is located in the endomysium and neuromuscular junctions, where it connects to the dystrophin-associated proteins through binding to a-dystroglycan. In developing newborn mice biglycan expression is initially high and then decreases during skeletal muscle differentiation and maturation. Biglycan may also have a role in the fibrotic process since it is overexpressed in atherosclerotic lesions and has been shown to cause an increase in thymidine incorporation and migration of vascular smooth muscle cells.Synonyms: BGN, Bone/cartilage proteoglycan I, PG-S1, PGS1, SLRR1A, Small Leucine-rich Protein 1A
    Poids moléculaire
    41.7 kDa (Human NP_001702.1 and Rat NP_058783.1)
    ID gène
    633
    NCBI Accession
    NP_001702
    UniProt
    P21810
    Pathways
    Glycosaminoglycan Metabolic Process
Vous êtes ici:
Support technique